Migraine Flashcards
what is the International Headache Society definition:
(1) a headache that lasts for 4-72 hours
(2) at least two of:
- unilateral localization
- pulsating quality
- moderate to severe pain intensity
- aggravation by movement
(3) at least one of:
- nausea and/or vomiting
- photophobia and phonophobia
what are the Four main phases of the migraine:
Four main phases of the migraine:
(i) premonitory, (ii) aura (e.g. visual), (iii) headache, and (iv) postdrome
what is the Pathophysiology of migraine
Theories have evolved from purely vascular to purely neurological
- Current thinking is that both are involved -> neurovascular
- Activation of trigeminovascular pathways -> meningeal vasodilation,
neurogenic inflammation, central sensitization, perceived head pain
Huff and Daly 2020. PMID: 29489263
Henry Gray – 1918 Gray’s Anatomy Plates
what is the target of the migraine medications
Agents that target the serotonin 5-HT 1 receptors
give two examples of the ergot alkaloids medications
ergotamine (no longer used in Canada)
(ii) dihydroergotamine
- nasal spray and injection (IV, SC, IM)
- high dose and drug interactions can cause adverse effects
how does First generation migraine medications work
ergot alkaloids
- act as an agonists at 5-HT 1B and 5-HT 1D receptors
- reduce trigeminal neuron activation, inducing vasoconstriction
of meningeal blood vessels
- are also agonists at additional 5-HT receptors and D1/D 2 receptors,
and likely other receptors
what is the Second generation anti migraine
Second generation: triptans
which receptor does triptans target
act as an agonists at 5-HT 1B and 5-HT 1D receptors
what is the effects of triptans on the Periphery
Periphery
(i) activation of 5-HT 1B receptors induces vasoconstriction
(ii) activation of 5-HT 1D receptors blocks the release of vasoactive
peptides that trigger neurogenic inflammation
what is the effects of triptans on the Central
Central
(iii) interference with afferent nociceptive signalling to the
trigeminocervical complex
what are the NSAIDS
NSAIDS
- non-specific agents: ibuprofen, diclofenac, and naproxen
- analgesic, antipyretic, anti-inflammatory
- inhibit cyclooxygenase (COX) 1- and 2-mediated synthesis of prostanoids
from arachidonic acid
where are the Calcitonin gene-related peptide (CGRP) located
Calcitonin gene-related peptide (CGRP)
- found in the sensory fibers from the dorsal root and trigeminal ganglia
- the CGRP receptor activates the Ga s G protein-coupled receptor
what is the erenumab injection
- for the prevention of migraine
- launched December of 2018
- humanized monoclonal antibody
against CGRP receptor - administered monthly by the
patient via AUTO injection - subcutaneous administration
what is the pathophysiology of Calcitonin gene-related peptide (CGRP)
Calcitonin gene-related peptide (CGRP)
- likely involved in migraine pathophysiology
(i) CGRP levels increased in serum and saliva during migraines
(ii) triptans lower CGRP levels
(iii) injection of CGRP induces headache in migraineurs
(iv) CGRP receptor antagonists relieve pain and other symptoms